Selected article for: "different study and efficacy safety"
Author: Xu Chen; Fang Zheng; Yanhua Qing; Shuizi Ding; Danhui Yang; Cheng Lei; Zhilan Yin; Xianglin Zhou; Dixuan Jiang; Qi Zuo; Jun He; Jianlei Lv; Ping Chen; Yan Chen; Hong Peng; Honghui Li; Yuanlin Xie; Jiyang Liu; Zhiguo Zhou; Hong Luo
Title: Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study
  • Document date: 2020_3_6
    • ID: 5ciaonf0_37
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03.03.20030353 doi: medRxiv preprint nearly half of our patients were still receiving treatment in hospital at the end of our follow-up and we could not decide the mortality and prognosis of the whole case series. Moreover, it is difficult to distinguish the specific efficacy of one single drug as various treatment were applied simultaneously, a.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03.03.20030353 doi: medRxiv preprint nearly half of our patients were still receiving treatment in hospital at the end of our follow-up and we could not decide the mortality and prognosis of the whole case series. Moreover, it is difficult to distinguish the specific efficacy of one single drug as various treatment were applied simultaneously, and the guideline about diagnosis and treatment of COVID-19 were updated frequently. Therefore, the treatment experience in our study should be carefully thought when treating patients in different places and circumstances, and further researches are needed to verify the the safety and efficacy.

    Search related documents:
    Co phrase search for related documents
    • case series and follow end: 1, 2, 3, 4, 5, 6
    • case series and hospital treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • case series and prognosis mortality: 1, 2
    • different place and hospital treatment: 1
    • efficacy safety and follow end: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • efficacy safety and hospital treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • efficacy safety and patient treat: 1, 2, 3, 4, 5, 6, 7
    • efficacy safety and prognosis mortality: 1, 2, 3
    • follow end and hospital treatment: 1, 2, 3, 4
    • hospital treatment and patient treat: 1, 2
    • hospital treatment and prognosis mortality: 1
    • nearly patient half and patient half: 1, 2, 3, 4, 5, 6, 7
    • patient treat and prognosis mortality: 1